MERRIMACK PHARMACEUTICALS INC Current Assets
MERRIMACK PHARMACEUTICALS INC had Current Assets of $244.32 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2024-05-15
- 2024-03-31: Assets, Current $244.32M.
- 2023-12-31: Assets, Current $19.18M.
- 2023-09-30: Assets, Current $19.29M.
- 2023-06-30: Assets, Current $19.44M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2024-03-31 | $244.32M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $19.18M 10-Q · filed 2024-05-15 | |
| 2023-09-30 | $19.29M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $19.44M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $19.63M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $19.83M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $13.63M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $14.04M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $14.61M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $14.68M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $15.19M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $15.71M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $16.25M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $16.54M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $18.68M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $19.37M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $19.97M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $18.69M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $22.40M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $42.56M 10-Q · filed 2019-07-17 | |
| 2019-03-31 | $63.69M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $76.10M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $87.27M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $61.73M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $77.11M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $95.05M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $115.58M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $141.56M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $46.27M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $57.44M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $89.62M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $119.03M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $160.68M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $201.39M 8-K · filed 2017-12-15 | |
| 2015-09-30 | $70.92M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $74.88M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $99.30M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $132.06M 10-K · filed 2016-02-26 | $132.10M 10-K · filed 2015-02-27 |
| 2014-09-30 | $162.14M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $103.85M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $138.88M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $166.64M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $200.28M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $85.95M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $106.75M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $128.30M 10-K · filed 2014-03-04 | |
| 2012-09-30 | $104.08M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $120.32M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $45.79M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $65.59M 10-K · filed 2013-03-20 |